Related Experiment Videos
[Clinicopathologic correlations in acute renal graft rejection]
S Pizzolitto1, G Boscutti, G Falconieri
1SOC di Anatomia Patologica, Azienda Ospedaliera Santa Maria della Misericordia Udine, Udine. pizzolitto.stefano@aoud.sanita.fvg.it
Summary
Acute graft rejection (AGR) in kidney transplants remains a concern. The BANFF classification improves diagnosis reproducibility over the NIH-CCTT system, but overall accuracy needs further enhancement for better patient outcomes.
Area of Science:
- Nephrology
- Transplantation immunology
- Pathology
Context:
- Acute graft rejection (AGR) poses a significant threat to renal transplant success, often leading to irreversible graft dysfunction.
- Renal biopsy is crucial for early post-transplant graft evaluation, detecting microscopic abnormalities for patient management.
- Histopathological assessment of AGR has historically faced challenges due to interobserver variability.
Purpose:
- To compare the diagnostic reproducibility and accuracy of the BANFF approach and the National Institute of Health Collaborative Clinical Trials in Transplantation (NIH-CCTT) system for acute graft rejection.
- To evaluate the effectiveness of current classification schemes in improving the diagnosis of AGR in renal transplantation.
Summary:
- The BANFF classification, emphasizing arteritis, tubulitis, and clinical information, has gained prominence over the NIH-CCTT system.
- The NIH-CCTT system includes criteria like interstitial hemorrhage, inflammatory infiltrate, and acute glomerulitis, alongside tubulitis and arteritis.
- While BANFF offers better reproducibility and prognostically relevant information for AGR assessment, significant improvements in diagnostic accuracy have plateaued in recent years.
Impact:
- The BANFF classification facilitates more accurate AGR assessment and improves diagnostic consistency among pathologists.
- Enhanced diagnostic tools are vital for timely intervention and improved long-term graft survival in renal transplant recipients.
- Further research is needed to enhance the accuracy trends in diagnosing acute graft rejection, despite advancements in classification systems.